Italia markets closed

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
25,73+0,15 (+0,59%)
In data: 12:12PM EDT. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente25,58
Aperto25,45
Denaro25,74 x 100
Lettera25,97 x 100
Min-Max giorno25,45 - 25,75
Intervallo di 52 settimane16,54 - 28,13
Volume5.610
Media Volume81.009
Capitalizzazione382,088M
Beta (5 anni mensile)0,75
Rapporto PE (ttm)N/D
EPS (ttm)-5,64
Prossima data utili08 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A30,33
  • GlobeNewswire

    Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023

    BEDFORD, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its third quarter 2023 financial results after the close of the market on Thursday, November 2, 2023 and hold its investor conference call on the same day, at 5:30 p.m. ET to discuss its financial results and business highlights. The conference call can be accessed by dialing 1-844-826-303

  • GlobeNewswire

    Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting

    RevoMotion™ Reverse Shoulder System showing smallest diameter threaded glenoid baseplate RevoMotion™ Reverse Shoulder System showing smallest diameter threaded glenoid baseplate Integrity™ Implant System Integrity™ Implant System RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion1 U.S. reverse shoulder market RevoMotion adds to a growing, highly differentiated portf

  • GlobeNewswire

    Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    BEDFORD, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 5, 2023, Anika granted restricted stock units ( “RSUs”) covering 10,000 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, was approved by the compensation committee of the board of directors pursuant to a